Use of memantine

ADMED_MEMANTINE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N06DX01

5856

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

4883

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

4883

diagram downward connector

Include endpoints None

4883

diagram downward connector
ADMED_MEMANTINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 4883 2105 2778
Unadjusted prevalence (%) 1.37 1.06 1.77
Mean age at first event (years) 79.72 79.83 79.64

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.14 8.14 [6.86, 9.66] <1e-100 2195
15 years 0.02 2.09 [1.75, 2.51] 8.6e-16 541
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ADMED_MEMANTINE – Use of memantine
GWS hits:

Survival analyses between endpoints

Plot

before Use of memantine
after Use of memantine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of memantine